Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
23 /100
LOW RISK
Score updated Oct 13, 2026

ANIP — ANI Pharmaceuticals, Inc. Dilution Risk Tracker

Track ANIP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ANIP — Get alerts when the score changes →

As of October 13, 2026, ANI Pharmaceuticals, Inc. (ANIP) has a DilutionWatch DilutionScore of 23/100, rated LOW dilution risk. ANI Pharmaceuticals, Inc. has a market capitalization of $1.80B, 24.42M shares outstanding, 282 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰Cash Runway—
📊 Float Risk
30
⚠️ Warrant Exposure
40
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for ANIP.
🔔 Track ANIP — Get forecast alerts →

Market Data

Market Cap$1.80B
Shares Outstanding24.42M
Float19.46M
Cash$360.21M
Debt$301.48M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore23/100DilutionWatch score record
Shares Outstanding24.42MVerified float table or market cache
Public Float19.46MVerified float table or market cache
Market Cap$1.80BMarket data cache
Cash RunwayNot applicable / unavailableDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 4 5, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 21.5% shares (2026Q1 vs prior)
282 institutional holders · 26.81M shares
#1 BlackRock, Inc. 2.75M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 1.65M shares
#3 Soleus Capital Management, L.P. 820.2K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.49M
Days to Cover7.2
% of Float17.9%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-02-27
4 INSIDER TRANSACTION 2026-03-13
4 INSIDER TRANSACTION 2026-03-13
4 INSIDER TRANSACTION 2026-03-10
4 INSIDER TRANSACTION 2026-03-10
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual ANIP Dilution Snapshot

ANI Pharmaceuticals, Inc. (ANIP) has a DilutionScore of 23/100, rated Low dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

ANIP's DilutionScore is currently 23/100 (Low risk), with 2 score changes tracked over 89 days. The score deteriorated from 26/100 (Medium risk).

Period Score Risk Level Duration
Aug 22 – Oct 13, 202623/100LOW53 days
Aug 14 – Aug 21, 202626/100MEDIUM7 days
Jul 16 – Aug 13, 202623/100LOW29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

ANIP shares outstanding have increased 1.4% from 22.41M (Mar 2026) to 22.73M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 19, 202622.73M19.46M▼ 0.02%
May 18, 202622.73M19.47M▼ 0.32%
May 17, 202622.73M19.53M▼ 0.58%
May 15, 202622.73M19.64M▲ 1.39%
May 11, 202622.75M19.37M▲ 0.18%
Apr 21, 202622.75M19.34M▲ 0.93%
Apr 18, 202622.75M19.16M▲ 0.81%
Mar 15, 202622.41M19.00M▲ 0.04%
Mar 13, 202622.41M19.00M▲ 0.22%
Mar 12, 202622.41M18.96M▼ 0.11%
Mar 10, 202622.41M18.98M▲ 0.63%
Mar 09, 202622.41M18.86M▲ 0.02%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track ANIP Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment ANIP files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking ANIP — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ANIP
ANIP FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.